## Background: Angiogenesis is a prerequisite to cancer growth and metastasis and is induced by a variety of angiogenic factors, including platelet-derived endothelial cell growth factor (pdecgf). the authors investigated the expression of pdecgf in 58 initial primary bladder carcinomas. ## Method
Circulating platelet-derived endothelial cell growth factor increases in hepatocellular carcinoma patients
โ Scribed by Kenji Jin-no; Masahito Tanimizu; Ichinosuke Hyodo; Yoshiyuki Nishikawa; Yasushi Hosokawa; Hisashi Endo; Toshihiko Doi; Koichi Mandai; Hideo Ishitsuka
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 463 KB
- Volume
- 82
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
โฆ Synopsis
classified into two groups based on TNM stage: early and advanced stage disease groups. PD-ECGF expressions in HCC tissues were immunohistologically examined.
๐ SIMILAR VOLUMES
## BACKGROUND. Platelet-derived endothelial cell growth factor (PD-ECGF) is an angiogenic factor that has potent chemotactic activity for endothelial cells. Although it is expressed in the majority of colorectal tumors, and some reports suggest that its high expression is related to poor prognosis,